Wells Fargo
TNGX icon

Wells Fargo’s Tango Therapeutics TNGX Stock Holding History

Wells Fargo’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.53M Buy
144,991
+103,019
+245% +$2.55M ﹤0.01% 2932
2026
Q1 		$878K Sell
41,972
-79,214
-65% -$1.1M ﹤0.01% 3811
2025
Q4 		$1.07M Buy
121,186
+66,181
+120% +$570K ﹤0.01% 3914
2025
Q3 		$462K Buy
55,005
+5,788
+12% +$39.2K ﹤0.01% 4361
2025
Q2 		$252K Buy
49,217
+26,422
+116% +$65.3K ﹤0.01% 4634
2025
Q1 		$31.2K Buy
22,795
+503
+2% +$1.24K ﹤0.01% 5552
2024
Q4 		$68.9K Buy
22,292
+7,599
+52% +$35.3K ﹤0.01% 5384
2024
Q3 		$113K Sell
14,693
-581
-4% -$5.54K ﹤0.01% 4940
2024
Q2 		$131K Sell
15,274
-539
-3% -$4.17K ﹤0.01% 4778
2024
Q1 		$126K Buy
15,813
+2,025
+15% +$21.7K ﹤0.01% 4762
2023
Q4 		$137K Buy
13,788
+2,717
+25% +$23.6K ﹤0.01% 4711
2023
Q3 		$125K Sell
11,071
-5,928
-35% -$36.1K ﹤0.01% 4650
2023
Q2 		$56.4K Buy
16,999
+8,731
+106% +$31.4K ﹤0.01% 5380
2023
Q1 		$32.7K Buy
+8,268
New +$48K ﹤0.01% 5395
2022
Q4 		– Sell
-96
Closed – – 7729
2022
Q3 		$0 Sell
96
-613
-86% -$2.62K ﹤0.01% 7369
2022
Q2 		$3K Buy
709
+316
+80% +$1.91K ﹤0.01% 6229
2022
Q1 		$3K Buy
393
+1
+0.3% +$9 ﹤0.01% 6602
2021
Q4 		$4K Buy
392
+1
+0.3% +$12 ﹤0.01% 6767
2021
Q3 		$5K Buy
+391
New +$4.69K ﹤0.01% 6386
2021
Q1 		– Sell
-8,568
Closed -$98K – 7374
2020
Q4 		$98K Buy
+8,568
New +$90.2K ﹤0.01% 5369

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Wells Fargo's TNGX Position: Q2 2026 in Review

Wells Fargo increased its Tango Therapeutics (TNGX) stake by 245% in Q2 2026, buying an estimated $2.55M and bringing the position to 144,991 shares worth $4.53M. The position accounts for ﹤0.01% of the portfolio, ranked #2932.

Wells Fargo first reported a position in TNGX in Q4 2020 and has held it in 20 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Wells Fargo held 144,991 shares of Tango Therapeutics worth $4.53M as of Q2 2026.
  • Wells Fargo bought 103,019 Tango Therapeutics shares in Q2 2026, an estimated $2.55M.
  • Tango Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #2932 holding.
  • Wells Fargo first reported a position in Tango Therapeutics in Q4 2020 and has held it in 20 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.